Today

Agents

Chat

Arena

Discover

More

App

Medincell notifies availability of press release - TEVA News | Rallies

Medincell notifies availability of press release

TEVA•2026-07-29

Press release on UZEDY sales and outlook

Medincell published a press release noting Teva’s U.S. net sales of UZEDY reached a record USD 77 million in Q2 2026, up 43% year on year.
Teva raised its 2026 UZEDY sales outlook to USD 270 million-USD 290 million from USD 250 million-USD 280 million.
Medincell said it receives mid- to high-single-digit royalties on net sales, with eligibility for USD 105 million in commercial milestones.
FDA action on Teva’s monthly long-acting olanzapine injection is expected in Q4 2026.

Related News

Nasdaq Trade Halt <DFNS.O> Volatility Trading Pause at 09:36 AM

DFNS•2026-07-29

General Dynamics CEO says co expects FY 2026 EPS of $16.80 to $16.90 - Conf. Call

GD•2026-07-29

Nasdaq Trade Halt <FIEE.O> Volatility Trading Pause at 09:59 AM

Sources

D

Medincell notifies availability of press release

Docs

2026-07-29

Pioneer Bancorp acquires College Advisor of New York to launch college advising division

PBFS•2026-07-29

P&G forecasts slower annual sales growth as costs weigh

PG•2026-07-29